BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 12877761)

  • 1. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients.
    Aronow WS
    Heart Dis; 2003; 5(4):279-94. PubMed ID: 12877761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure.
    Aronow WS
    Cardiol Rev; 2006; 14(3):108-24. PubMed ID: 16628020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of systolic and diastolic heart failure in the elderly.
    Aronow WS
    J Am Med Dir Assoc; 2006 Jan; 7(1):29-36. PubMed ID: 16413432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of systolic and of diastolic heart failure in elderly persons.
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2005 Dec; 60(12):1597-605. PubMed ID: 16424295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic heart failure.
    Frigerio M; Aguggini G
    Ital Heart J; 2004 Jun; 5 Suppl 6():48S-54S. PubMed ID: 15185915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of congestive heart failure in the elderly patient.
    Aronow WS
    Compr Ther; 1995 Jul; 21(7):329-38. PubMed ID: 7554808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Older Patients With CHF Associated With Normal LVEF.
    Aronow WS
    Am J Geriatr Cardiol; 1998 Nov; 7(6):27-31. PubMed ID: 11416478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of congestive heart failure in elderly persons.
    Aronow WS
    Compr Ther; 1997 Oct; 23(10):639-47. PubMed ID: 9327179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.